Welcome to this week’s Women’s Health Weekly, a bite-sized round-up of some of the latest research, news and developments shaping women’s health.
This week, I’m looking at new research into why bacterial vaginosis can keep coming back, what medically induced menopause could mean for long-term cardiovascular health, and new evidence around GLP-1 medications and pregnancy.
IN THIS WEEK’S EPISODE
- Why bacterial vaginosis (BV) can keep coming back after treatment
- The role reinfection and the vaginal microbiome may play in recurrent BV
- Medically induced menopause and long-term cardiovascular health
- Why experiencing medically induced menopause before 45 may matter
- What new research tells us about GLP-1 medications and pregnancy
- Why the early findings are reassuring, but significant evidence gaps remain
RESEARCH & FURTHER READING
Recurrent bacterial vaginosis The Lancet Obstetrics, Gynaecology & Women’s Health research into recurrent BV and treatment failure
Read the research
Research summary - recurrent BV, reinfection and treatment
Read the research summary
Medically induced menopause & cardiovascular health
JAMA Network Open – systematic review and meta-analysis of cardiovascular outcomes following iatrogenic menopause
Read the research
GLP-1 medications & pregnancy
International systematic review and expert consensus on GLP-1 receptor agonist use around pregnancy
Read the research summary
Follow Owning Space wherever you’re listening so you don’t miss the next Women’s Health Weekly, released every Monday morning.
For more conversations around women’s health, our bodies and the stories that deserve more space, follow @owningspacepodcast on Instagram and TikTok.
And if there’s a story, study or development you think I should cover in a future episode, send it my way.
Until next week, keep taking up space. 💛
